Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Not Confirmed
Not Confirmed
24-27 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
BIO Asia-TaiwanBIO Asia-Taiwan
Industry Trade Show
Not Confirmed
24-27 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
07 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/07/3111003/0/en/Silo-Pharma-Advances-PTSD-Drug-SPC-15-Toward-Planned-2025-IND-Submission-with-Pre-Clinical-Study-Data-Expected-in-Q3-2025.html
25 Jun 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/hoth-therapeutics-hoth-and-silo-pharma-nasdaq-silo-today-announced-the-formation-of-a-5050-joint-venture-to-develop-a-first-in-class-gdnf-based-therapy-licensed-from-the-us-department-of-veterans-affairs-the-therapy-targe-302490308.html
25 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/25/3105102/0/en/Silo-Pharma-Enters-into-Letter-of-Intent-to-Form-Joint-Venture-with-Hoth-Therapeutics-to-Develop-Obesity-Treatment-Targeting-16-Billion-Global-Market.html
11 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/11/3097579/0/en/Silo-Pharma-Secures-Biomarker-Patent-for-Novel-PTSD-Therapeutic-SPC-15-as-Clinical-Trial-Nears.html
05 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/05/3094451/0/en/Silo-Pharma-Board-of-Directors-Approves-Purchase-of-Bitcoin-as-Treasury-Reserve-Asset.html
21 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/21/3085740/0/en/Silo-Pharma-Partners-with-Resyca-for-IND-Supporting-Intranasal-Drug-Device-Study-of-PTSD-Drug-SPC-15.html
ABOUT THIS PAGE